Even the Abbott antibody test which is considered a good one is backed by a disturbingly small clinical study. The positive result pool had a sample size of aro

Even the Abbott antibody test which is considered a good one is backed by a disturbingly small clinical study. The positive result pool had a sample size of around 75 people, and 1k negatives. I read the reagent insert for this. Then when labs are running this test, they have very poor correlation studies that are essentially useless. Everyone is trying to rush these tests out the door. I agree that they should start running them at scale, but all the data needs to be centralized and analyzed. They also need to bring in a lot of previously RNA tested positive COVID patients and see how many test positive. The problem with all these fragmented efforts with 100 different tests is that we never get the full picture or a good sample pool. I think the FDA does need to apply the brakes here a bit and get this going.